Member Info for Laura2022

No doubt you'll ignore debating these points or justifying your obsession with VAL and instead simply revert to type and accuse myself and others of being 3 or 4 different people

What exactly is your 3 year obsession with VAL ?

Honest answers....if you can muster that

Porky

So much for your Christmas wishes on 27th , you've simply reverted to type

As for this

"admin costs remain obscene and I consider excessive with zero attempt to get any control of costs. "

GDR overheads are £400,000 a month ?

Also you complain of salaries here yet GDR CEO on £300k+

Should see a breakout tommorow/Friday as charts so oversold

Happy new year to IES and shareholders

2025 the year where PYC can hopefully get to a more realistic valuation of £10mln which is only 10 x past years revenues and probably will drop to x 7 or less if PYC continues on the path to hitting £1.5mln revenues June 2024 to June 2025 ( c £800/900k already won H1)

Because they know 0.7p/£900k is undervalued

They said this on 20th Dec 2024 when shar price was 2.5p

In conjunction with the difficult trading environment highlighted in the point above, this has negatively affected the share price of Quiz and therefore its market capitalisation, which the Directors does not believe accurately reflects potential or underlying prospects of the business.

It was the 108 shares UT not a real trade

Hny both

Can't speak for ROQ other than we are a A.I support company rather than trying to iut license drugs

As newuncle says £1.5mln cap with already £800-900k revenues booked June to Dec 2024 ( highest ever H1) and cash of £700k

The big one is the potential sdeal with NASDAQ listed DoseMeRX to fully intergraye our dosing tool USA/EU

( See posts from Kinghomer and Trench123)

The only risk is holding past the 22nd Jan

These ones always move upwards and now added incentive as insiders have gone 8% to 10% last week

Charts are capitulated and 1% tony chance of an offer

It willing to hold for 3 weeks i think it does 100%

The 1.5mln was a worked buy

As was the £21k yesterday morning

Bunsen

Santa is latest re incarnation of a LSE moron Neil777

Look at Santas antics and U turns on GEX

Filter and ignore

Santa/Neil777/investorace

And all your other IDS

Move on

Typical Bell style

NYE

Hi ian

Yes, many would agree also very similar to FAB in terms of sector

CEO here has totally transformed the company propects in just 9mths and also one of lowest salaries on AIM ( £72k v £250k AIM average)

Lots of uplifts from £1.5mln market cap with record revenues booked in 2024 and growing importance for FDA requirements on drug discovery programmes

HNY Ian

Here is a quick summarising if it helps

£1.5mln cap

£600-700k cash ,no debt small losses

CE0 salary £72k is 1/4 of AIM average = modest and alligned

Record contracts won June 2023 to June 2024 £1mln

Record revenues going into end of H1 2024 of currently £800-900k (up to Dec 2024)

Only needs about £1.4mln FY revenues end of June 2025 to probably turn to profit

Working in niche A.I software development market worth $blns

New CEO made huge impact in just 9mths

Potentially very large bio statistic contracts to come (words of BOD at last presentation)

Access to EU and USA markets via NASDAQ partners

VAL confirmed 31st Dec that the out licence of VAL201 which PYC collaboration on will have further details soon ( see VAL RNS 31st Dec) 6

Ian

Good to see you here

Hny

Can sell over 1mln at 0.73

Or GWMO